Repligen (RGEN) News Today $117.54 -3.47 (-2.87%) Closing price 06/18/2025 04:00 PM EasternExtended Trading$145.50 +27.96 (+23.79%) As of 06/18/2025 04:51 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock RGEN Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 Time Period Conestoga Capital Advisors LLC Purchases 32,665 Shares of Repligen Co. (NASDAQ:RGEN)Conestoga Capital Advisors LLC increased its position in Repligen Co. (NASDAQ:RGEN - Free Report) by 3.4% in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 980,247 shares of the biotechnology company's stockJune 17 at 5:20 AM | marketbeat.comTrust Point Inc. Trims Holdings in Repligen Co. (NASDAQ:RGEN)Trust Point Inc. decreased its position in shares of Repligen Co. (NASDAQ:RGEN - Free Report) by 35.1% during the first quarter, according to its most recent filing with the SEC. The firm owned 3,756 shares of the biotechnology company's stock after selling 2,030 shares during the period. Trust PoiJune 17 at 4:17 AM | marketbeat.comRepligen (NASDAQ:RGEN) Shares Down 3.1% - Should You Sell?Repligen (NASDAQ:RGEN) Trading Down 3.1% - What's Next?June 16 at 2:38 PM | marketbeat.comAzzad Asset Management Inc. ADV Acquires Shares of 21,077 Repligen Co. (NASDAQ:RGEN)Azzad Asset Management Inc. ADV bought a new position in shares of Repligen Co. (NASDAQ:RGEN - Free Report) in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm bought 21,077 shares of the biotechnology company's stock, vJune 15, 2025 | marketbeat.comRepligen Co. (NASDAQ:RGEN) Receives $173.25 Average PT from AnalystsJune 14, 2025 | americanbankingnews.comRepligen Co. (NASDAQ:RGEN) Receives Consensus Rating of "Moderate Buy" from AnalystsRepligen Co. (NASDAQ:RGEN - Get Free Report) has been given an average recommendation of "Moderate Buy" by the fourteen brokerages that are covering the stock, Marketbeat reports. Five analysts have rated the stock with a hold recommendation and nine have given a buy recommendation to the company.June 11, 2025 | marketbeat.comRepligen: Long-Term Growth Gem Suffers Some SetbacksJune 8, 2025 | seekingalpha.comCongress Asset Management Co. Grows Holdings in Repligen Co. (NASDAQ:RGEN)Congress Asset Management Co. grew its holdings in shares of Repligen Co. (NASDAQ:RGEN - Free Report) by 10.8% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 129,219 shares of the biotechnology company's stock aJune 8, 2025 | marketbeat.comNBC Securities Inc. Purchases 2,672 Shares of Repligen Co. (NASDAQ:RGEN)NBC Securities Inc. raised its stake in Repligen Co. (NASDAQ:RGEN - Free Report) by 133,600.0% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 2,674 shares of the biotechnology company's stock after acquiring an addJune 7, 2025 | marketbeat.comGAMMA Investing LLC Has $15.51 Million Stock Position in Repligen Co. (NASDAQ:RGEN)GAMMA Investing LLC raised its stake in Repligen Co. (NASDAQ:RGEN - Free Report) by 17,721.1% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 121,896 shares of the biotechnology company's stoJune 7, 2025 | marketbeat.comDrug Development Inputs & Services Stocks Q1 In Review: Repligen (NASDAQ:RGEN) Vs PeersJune 5, 2025 | finance.yahoo.comCraig-Hallum Sticks to Its Buy Rating for Repligen (RGEN)June 5, 2025 | theglobeandmail.comWinners And Losers Of Q1: Repligen (NASDAQ:RGEN) Vs The Rest Of The Drug Development Inputs & Services StocksJune 5, 2025 | msn.comHarbor Investment Advisory LLC Has $373,000 Stake in Repligen Co. (NASDAQ:RGEN)Harbor Investment Advisory LLC grew its holdings in shares of Repligen Co. (NASDAQ:RGEN - Free Report) by 289.0% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 2,929 shares of the biotechnology company's stockJune 4, 2025 | marketbeat.comRepligen at William Blair Conference: Innovation Drives GrowthJune 3, 2025 | investing.comRepligen Co. (NASDAQ:RGEN) Stock Holdings Cut by Squarepoint Ops LLCSquarepoint Ops LLC reduced its position in shares of Repligen Co. (NASDAQ:RGEN - Free Report) by 85.1% in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 14,291 shares of the biotechnology company's stock after selling 81,8May 30, 2025 | marketbeat.comRepligen Co. (NASDAQ:RGEN) Position Raised by Polar Asset Management Partners Inc.Polar Asset Management Partners Inc. increased its position in shares of Repligen Co. (NASDAQ:RGEN - Free Report) by 76.9% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 6,900 sMay 29, 2025 | marketbeat.comTidal Investments LLC Decreases Position in Repligen Co. (NASDAQ:RGEN)Tidal Investments LLC lessened its holdings in Repligen Co. (NASDAQ:RGEN - Free Report) by 60.2% in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 4,437 shares of the biotechnology company's stock after selling 6,712 shares durMay 29, 2025 | marketbeat.comUBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Has $33.88 Million Stock Position in Repligen Co. (NASDAQ:RGEN)UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its stake in shares of Repligen Co. (NASDAQ:RGEN - Free Report) by 12.8% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 235,May 28, 2025 | marketbeat.comRepligen Announces Publication of the Company’s 2024 Corporate Sustainability ReportMay 27, 2025 | finance.yahoo.comRepligen Announces Publication of the Company's 2024 Corporate Sustainability ReportMay 27, 2025 | investing.comRepligen Announces Publication of the Company's 2024 Corporate Sustainability ReportMay 27, 2025 | globenewswire.comRepligen Co. (NASDAQ:RGEN) Shares Bought by Two Sigma Advisers LPTwo Sigma Advisers LP lifted its holdings in Repligen Co. (NASDAQ:RGEN - Free Report) by 6.7% during the fourth quarter, according to the company in its most recent filing with the SEC. The fund owned 134,800 shares of the biotechnology company's stock after buying an additional 8,500 shares duringMay 24, 2025 | marketbeat.comRepligen Co. (NASDAQ:RGEN) Shares Sold by AWM Investment Company Inc.AWM Investment Company Inc. lowered its stake in shares of Repligen Co. (NASDAQ:RGEN - Free Report) by 7.1% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 65,000 shares of the biotechnology company'sMay 23, 2025 | marketbeat.comTeza Capital Management LLC Sells 10,705 Shares of Repligen Co. (NASDAQ:RGEN)Teza Capital Management LLC cut its holdings in Repligen Co. (NASDAQ:RGEN - Free Report) by 78.6% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 2,921 shares of the biotechnology company's stock aMay 23, 2025 | marketbeat.comRepligen Corporation to Present at William Blair Growth ConferenceMay 22, 2025 | uk.finance.yahoo.comTwo Sigma Investments LP Lowers Stake in Repligen Co. (NASDAQ:RGEN)Two Sigma Investments LP reduced its position in Repligen Co. (NASDAQ:RGEN - Free Report) by 17.7% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 359,039 shares of the biotechnology company's stockMay 22, 2025 | marketbeat.comPoint72 Asia Singapore Pte. Ltd. Trims Stock Position in Repligen Co. (NASDAQ:RGEN)Point72 Asia Singapore Pte. Ltd. lowered its stake in shares of Repligen Co. (NASDAQ:RGEN - Free Report) by 98.5% in the fourth quarter, according to its most recent 13F filing with the SEC. The fund owned 206 shares of the biotechnology company's stock after selling 13,770 shares during the periodMay 22, 2025 | marketbeat.comNuveen Asset Management LLC Decreases Stock Position in Repligen Co. (NASDAQ:RGEN)Nuveen Asset Management LLC lowered its stake in Repligen Co. (NASDAQ:RGEN - Free Report) by 13.0% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 291,537 shares of the biotechnology company's stock after selMay 22, 2025 | marketbeat.comPolar Asset Management Partners Inc. Buys 3,000 Shares of Repligen Co. (NASDAQ:RGEN)Polar Asset Management Partners Inc. increased its stake in Repligen Co. (NASDAQ:RGEN - Free Report) by 76.9% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 6,900 shares of the biotechnology company's stock after purchasingMay 20, 2025 | marketbeat.comGotham Asset Management LLC Has $965,000 Stake in Repligen Co. (NASDAQ:RGEN)Gotham Asset Management LLC decreased its position in shares of Repligen Co. (NASDAQ:RGEN - Free Report) by 78.5% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 6,702 shares of the biotechnoloMay 20, 2025 | marketbeat.comRepligen Co. (NASDAQ:RGEN) Given Average Recommendation of "Moderate Buy" by AnalystsRepligen Co. (NASDAQ:RGEN - Get Free Report) has earned a consensus rating of "Moderate Buy" from the fourteen ratings firms that are covering the company, Marketbeat reports. Five equities research analysts have rated the stock with a hold recommendation and nine have assigned a buy recommendatioMay 19, 2025 | marketbeat.comBank of America Corp DE Trims Holdings in Repligen Co. (NASDAQ:RGEN)Bank of America Corp DE trimmed its stake in Repligen Co. (NASDAQ:RGEN - Free Report) by 36.3% during the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 277,947 shares of the biotechnology company's stock after selling 158,404 shares during the period. Bank ofMay 18, 2025 | marketbeat.comPoint72 Asset Management L.P. Has $132.23 Million Stake in Repligen Co. (NASDAQ:RGEN)Point72 Asset Management L.P. lifted its stake in shares of Repligen Co. (NASDAQ:RGEN - Free Report) by 183.1% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 918,623 shares of the biotechnology company's stock after acquiriMay 17, 2025 | marketbeat.comInsider Sell: Anthony Hunt Sells 26,447 Shares of Repligen Corp (RGEN)May 17, 2025 | gurufocus.comRepligen Holds Annual Shareholders Meeting, Key Decisions MadeMay 15, 2025 | tipranks.comIntegral Health Asset Management LLC Purchases New Holdings in Repligen Co. (NASDAQ:RGEN)Integral Health Asset Management LLC acquired a new stake in Repligen Co. (NASDAQ:RGEN - Free Report) in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm acquired 40,000 shares of the biotechnology company's stock, valued at appMay 14, 2025 | marketbeat.comAlgert Global LLC Invests $844,000 in Repligen Co. (NASDAQ:RGEN)Algert Global LLC purchased a new stake in Repligen Co. (NASDAQ:RGEN - Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm purchased 5,865 shares of the biotechnology company's stock, valued at approximaMay 13, 2025 | marketbeat.comRepligen, Bruker, Agilent, Medpace, and Revvity Shares Skyrocket, What You Need To KnowMay 12, 2025 | msn.comRepligen (NASDAQ:RGEN) Stock Unloaded Rep. Jefferson ShreveRepresentative Jefferson Shreve (R-Indiana) recently sold shares of Repligen Co. (NASDAQ:RGEN). In a filing disclosed on May 08th, the Representative disclosed that they had sold between $15,001 and $50,000 in Repligen stock on April 7th. The trade occurred in the Representative's "CRT - STANDARD UMay 12, 2025 | marketbeat.comGranahan Investment Management LLC Acquires 19,160 Shares of Repligen Co. (NASDAQ:RGEN)Granahan Investment Management LLC increased its holdings in shares of Repligen Co. (NASDAQ:RGEN - Free Report) by 21.7% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 107,415 shares of the biotechMay 12, 2025 | marketbeat.comFred Alger Management LLC Sells 39,047 Shares of Repligen Co. (NASDAQ:RGEN)Fred Alger Management LLC reduced its position in Repligen Co. (NASDAQ:RGEN - Free Report) by 9.8% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 359,507 shares of the biotechnology company's stock after sellMay 10, 2025 | marketbeat.comAmeriprise Financial Inc. Sells 25,168 Shares of Repligen Co. (NASDAQ:RGEN)Ameriprise Financial Inc. lessened its stake in shares of Repligen Co. (NASDAQ:RGEN - Free Report) by 2.6% during the fourth quarter, according to the company in its most recent disclosure with the SEC. The fund owned 929,090 shares of the biotechnology company's stock after selling 25,168 shares dMay 10, 2025 | marketbeat.comRepligen (NASDAQ:RGEN) Upgraded to "Hold" at StockNews.comStockNews.com upgraded Repligen from a "sell" rating to a "hold" rating in a research report on Thursday.May 10, 2025 | marketbeat.comBridgefront Capital LLC Makes New Investment in Repligen Co. (NASDAQ:RGEN)Bridgefront Capital LLC acquired a new stake in shares of Repligen Co. (NASDAQ:RGEN - Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The firm acquired 3,904 shares of the biotechnology company's stock, valued at approximately $562,000. A nuMay 8, 2025 | marketbeat.comBayesian Capital Management LP Makes New $947,000 Investment in Repligen Co. (NASDAQ:RGEN)Bayesian Capital Management LP purchased a new stake in Repligen Co. (NASDAQ:RGEN - Free Report) in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor purchased 6,578 shares of the biotechnology company's stock, valMay 8, 2025 | marketbeat.comNorthern Trust Corp Has $71.07 Million Position in Repligen Co. (NASDAQ:RGEN)Northern Trust Corp increased its position in shares of Repligen Co. (NASDAQ:RGEN - Free Report) by 26.0% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 493,713 shares of the biotechnMay 8, 2025 | marketbeat.comRepligen Co. (NASDAQ:RGEN) Shares Sold by The Manufacturers Life Insurance CompanyThe Manufacturers Life Insurance Company decreased its holdings in shares of Repligen Co. (NASDAQ:RGEN - Free Report) by 3.7% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 64,199 shares of the biotechnology company's stocMay 8, 2025 | marketbeat.comRepligen's (RGEN) "Buy" Rating Reaffirmed at HC WainwrightHC Wainwright reiterated a "buy" rating and issued a $180.00 price objective on shares of Repligen in a report on Monday.May 7, 2025 | marketbeat.comRepligen Corporation to Present at Upcoming May Investor ConferencesMay 7, 2025 | globenewswire.com Get Repligen News Delivered to You Automatically Sign up to receive the latest news and ratings for RGEN and its competitors with MarketBeat's FREE daily newsletter. Email Address RGEN Media Mentions By Week RGEN Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. RGEN News Sentiment▼1.220.66▲Average Medical News Sentiment RGEN News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. RGEN Articles This Week▼59▲RGEN Articles Average Week Get Repligen News Delivered to You Automatically Sign up to receive the latest news and ratings for RGEN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Biogen News Incyte News United Therapeutics News Neurocrine Biosciences News Exelixis News BioMarin Pharmaceutical News Exact Sciences News Halozyme Therapeutics News Madrigal Pharmaceuticals News Ionis Pharmaceuticals News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:RGEN) was last updated on 6/19/2025 by MarketBeat.com Staff From Our PartnersYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Robots aren't coming to America in 2025. They are already here. Oxford Economics says, "The Robotics Rev...Weiss Ratings | SponsoredWhy July 22nd Could Mean Big Changes for Social SecurityIn a stunning move, President Trump has authorized an AI-led transformation of federal agencies, including Soc...Altimetry | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Repligen Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share Repligen With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
